Higher expression of NFKB1 and SATB1, which are involved in regulating PD1 expression (Nixon and Li, 2017; Antonangeli et al., 2020) was only observed in patients with lower-grade gliomas. This evidence concerns the gene NFKB1 and central nervous system cancer.